InMed Pharmaceuticals INM
$ 4.33
4.59%
Quarterly report 2024-Q3
added 11-14-2024
InMed Pharmaceuticals Financial Ratios 2011-2024 | INM
Annual Financial Ratios InMed Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.2 | -0.2 | -0.0 | -3.9 | - | - | - | - | - | - | - | - | - |
P/S |
0.4 | 2.8 | 0.1 | - | - | - | - | - | - | - | - | - | - |
EPS |
-3.2 | -33.2 | -38.0 | -1.7 | - | - | - | - | - | - | - | - | - |
EV (Enterprise Value) |
-5.18 M | 555 K | -4.69 M | 43.5 M | 1.56 M | 938 K | 370 K | 590 K | 77.6 K | 74.8 K | 51.8 K | 45.4 K | 44.8 K |
EBITDA per Share |
-3.16 | -32.8 | -37.5 | -2.28 | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
14.6 | -3.3 | - | - | - | - | - | - | - | - | - | ||
PEG |
- | 1.55 | - | - | - | - | - | - | - | - | - | ||
P/B |
0.1 | 0.3 | 0.0 | 6.1 | - | - | - | - | - | - | - | - | - |
P/CF |
-0.2 | -0.2 | -0.0 | -4.8 | - | - | - | - | - | - | - | - | - |
ROE % |
-65.74 | -204.88 | -138.32 | -155.57 | - | - | - | - | - | - | - | - | - |
ROA % |
-56.34 | -145.45 | -104.31 | -115.74 | - | - | - | - | - | - | - | - | - |
ROCE % |
-65.74 | -204.88 | -138.32 | -148.96 | - | - | - | - | - | - | - | - | - |
Current Ratio |
7.0 | 3.4 | 4.1 | 3.8 | - | - | - | - | - | - | - | - | - |
DSO |
3.8 | 5.3 | 1.1 | - | - | - | - | - | - | - | - | - | - |
DIO |
309.3 | 832.7 | - | - | - | - | - | - | - | - | - | - | - |
DPO |
128.8 | 389.8 | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
313.1 | 838.1 | 1.1 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
184.3 | 448.2 | 1.1 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios InMed Pharmaceuticals
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-2.71 | - | -0.19 | -15.24 | - | -0.6 | -0.91 | -4.06 | -3.54 | -6.14 | -7.73 | -6.17 | -14.03 | -0.41 | -0.37 | -0.31 | -0.37 | -0.31 | -0.48 | -0.54 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | -0.59 | -0.89 | -4 | -8.47 | -6.05 | -7.64 | -6.11 | -13.9 | -0.41 | -0.36 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-16.65 | -1.22 | -17.34 | -20.43 | -62.67 | -124.48 | -140.28 | -155.85 | -143.49 | -180.02 | -168.47 | -167.80 | -169.34 | -100.56 | -115.77 | -112.15 | -115.55 | -85.99 | -50.41 | -24.46 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-35.41 | -23.25 | -36.82 | -39.55 | -50.05 | -93.93 | -102.81 | -112.49 | -105.57 | -135.86 | -145.12 | -142.13 | -149.19 | -103.78 | -92.57 | -73.47 | -49.25 | -20.49 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
- | -16.13 | -32.26 | -46.91 | -62.67 | -124.48 | -140.28 | -155.85 | -143.49 | -180.02 | -168.47 | -167.80 | -148.28 | -49.93 | -29.56 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
5.1 | 4.5 | 6.1 | - | 7.0 | 6.3 | 6.5 | 4.1 | 3.5 | 3.4 | 3.7 | 8.2 | 4.1 | 4.1 | 2.8 | 3.1 | 4.0 | 4.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
12.7 | - | - | - | - | 11.1 | 9.4 | 14.7 | 9.2 | 17.8 | 11.2 | 1.2 | 4.1 | 17.4 | 34.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
145.8 | - | - | - | - | 159.6 | 457.0 | 828.8 | 311.1 | 863.4 | 293.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
2.5 | - | - | - | - | 81.8 | 251.6 | 439.2 | 92.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
158.5 | - | 149.4 | - | - | 170.7 | 466.4 | 843.5 | 320.2 | 881.2 | 305.1 | 1.2 | 4.1 | 17.4 | 34.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
155.9 | - | 97.3 | - | - | 88.9 | 214.9 | 404.3 | 227.5 | 881.2 | 305.1 | 1.2 | 4.1 | 17.4 | 34.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency